Elephas Valuation, Funding & Investors

Pangaea Oncology SA is a medical services company. The company provides a wide range of services to cancer patients, as well as global pharmaceutical and biotech clients, in the fields of molecular diagnostics, clinical trials, in vitro drug profiling, dx platform validation, and biomarker discovery. The company has aggregated its operations into two segments, Clinical Care division and Diagnostic and Research and Development services division. Clinical Care division delivers medical oncology services and related activities. Diagnostic and Research and Development services division provides diagnostic and in-vitro services.

Sirona Medical is a San Francisco-headquartered provider of cloud-native radiology software. Its platform consolidates worklists, image viewers, reporting tools, archives, and AI integrations into a unified workspace for radiologists. Designed for high-volume reading environments, Sirona supports PACS, RIS, and voice recognition features across web and mobile. The company serves imaging centers and hospitals in the United States, focusing on workflow efficiency and remote diagnostics. Sirona Medical integrates with major EMR systems like Epic and Cerner to streamline enterprise radiology operations.

JLK Inc, formerly JLK Inspection Inc is a South Korea based company engaged in providing AI Medical Solutions and AI Security Solutions. Some of its solutions include Atroscan, HandMed, Funduscan, Unistro and Unipros.

Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses, and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective, and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices, and other services. Geographically, the company generates the majority of its revenue from Mainland China.

Razor Labs Ltd is engaged in the business of developing artificial intelligence based products and solutions for businesses.

Ever Fortune.AI Co Ltd is composed of establishing a cloud medical platform based on medical big data, and to provide customized medical artificial intelligence solutions and services in various biomedical fields. The results both provide a professional second opinion for doctors and assist clinical doctors in making a medical diagnosis, which in turn raises the speed, accuracy, and efficiency of medical decisions. The products of the company include: Medical Artificial Intelligence, Cloud Biomedical Platform, and Medical Big Data. Its segments are: Medical AI Department; Biotechnology Department; and Others, where maximum revenue is derived from Biotechnology Department segment.

Infinitt Healthcare Co Ltd is a Korea-based company engaged in developing digital solutions used in hospitals. The company offers clinical solutions, enterprise imaging solutions and radiology solutions. The solutions offered by the company are enterprise imaging, radiology, cardiology, pathology, dental imaging, and other cloud solutions.

Ascom Holding AG is a solutions provider focused on healthcare ICT and mobile workflow solutions. The company consists of a business unit, the purpose of which is to use its product and solutions portfolio and software architecture capabilities to devise integration and mobilization solutions that provide digitalized, complete, and efficient workflows for healthcare as well as for industry, security, and retail sectors. The company has three segments OEM, Enterprise, and Healthcare. It derives a majority of its revenue from the healthcare segment.

Susmed Inc is engaged in the development of therapeutic smartphone apps and digital solutions to streamline clinical trials. It is currently developing therapeutic apps for patients with insomnia, breast cancer, kidney disease, and other conditions. In addition, it has developed Susumed System, which uses a proprietary blockchain technology to ensure the reliability of clinical trial data, and can reduce the manpower and costs allocated to clinical trials. The company's reportable segments are: the DTx Product Business, which derives maximum revenue, and consists of the development of therapeutic apps; and the DTx Platform Business, which provides general-purpose clinical trial systems and machine learning automated analysis systems.

SMAIO SA is engaged in offering spine surgeons a complete solution, consisting of software, implantable devices, and associated services, to treat spinal pathologies requiring surgery.